The Alzheimer’s Association recently awarded Jose Abisambra, assistant professor at the University of Kentucky and researcher at the Sanders-Brown Center on Aging, a $100,000 New Investigator Research Grant to fund his work into understanding the function of a brain protein that alters during the development of Alzheimer’s disease. The…
Amarantus BioScience Holdings, Inc. recently released promising results from the Lymphocyte Proliferation Test (LymPro Test®) blood diagnostic for Alzheimer’s disease (AD) LP-002 study. Amarantus is a biotechnology company focused on research and development of treatments and diagnostics for diseases related to neurodegenerative and apoptosis (programmed cell death) processes that contribute…
Muses Labs, based at Research Triangle Park in Raleigh, North Carolina, creates software-based systems to enable personalized therapy for the treatment of complex diseases. The company recently announced the development of its first offering for addressing Alzheimer’s disease. The combination therapy it implements is based on a broad understanding…
New diagnostics are currently being developed by researchers to help doctors ascertain risk factors for Alzheimer’s Disease before the onset of symptoms. A recent study showed that a brain scan lasting no longer than 5 minutes could potentially yield results indicative of dementia risk by determining…
Avanir Pharmaceuticals, Inc. will present their most-recent results from two clinical trials currently underway for treating conditions associated with Alzheimer’s disease (AD). The data is set to be presented at the American Neurological Association’s (ANA) Annual Meeting in Baltimore, Maryland, from October 12-14, 2014. The phase II clinical trial evaluated…
The 2014 Nobel prize in physiology or medicine was recently awarded to three scientists for their discovery of brains’ cells that report animals’ position in space, which therefore is being referred to as the brain’s “internal GPS.” The prize is divided between John O’Keefe, PhD, director of the Sainsbury…
The Massachusetts Institute of Technology (MIT) AgeLab recently joined forces with the Transamerica companies to discuss significant financial issues regarding patients suffering from Alzheimer’s and their families, as well as to initiate a framework for new guidelines in effectively serving clients facing the disease. The meeting recently took place at the “Financial…
A novel, personalized treatment program with the ability to reverse the cognitive impairment caused by Alzheimer’s disease may have been discovered by a researcher from the Buck Institute Research on Aging, in Novato, California and the University of California-Los Angeles. The findings of the study, which focused on combined therapies…
Scientists from Yale School of Medicine are calling on willing participants for one of two clinical trials for pharmaceutical treatments against Alzheimer’s disease, which until this day, scientists have yet to find a cure for. The only drugs available on the market today are…
Hannink and Jasmer discovered a molecule that treats oxidative stress. Credit: Randy Mertens, CAFNR A new molecule capable of fighting oxidative stress, with high potential to be developed into a drug in pill form, has been identified by researchers at the University of Missouri (MU). This…
Get regular updates to your inbox.